HomeNewsWorldDelta dominant variant in US, makes up more than half of COVID-19 cases: CDC

Delta dominant variant in US, makes up more than half of COVID-19 cases: CDC

The variant, also known as B.1.617.2, was first detected in India in December and is spreading quickly across the globe. In some parts of America, the delta strain accounts for more than 80 per cent of new infections, including some Midwestern states like Missouri, Kansas and Iowa.

July 07, 2021 / 14:45 IST
Story continues below Advertisement
In its COVID-19 Weekly Epidemiological Update, the WHO said as of June 29, 2021, "96 countries have reported cases of the Delta variant, though this is likely an underestimate as sequencing capacities needed to identify variants are limited. A number of these countries are attributing surges in infections and hospitalisations to this variant."
In its COVID-19 Weekly Epidemiological Update, the WHO said as of June 29, 2021, "96 countries have reported cases of the Delta variant, though this is likely an underestimate as sequencing capacities needed to identify variants are limited. A number of these countries are attributing surges in infections and hospitalisations to this variant."

The highly contagious Delta variant has become the dominant coronavirus strain in the US, accounting for more than 51 per cent of Covid infections in the country, according to new data released by the Centres for Disease Control and Prevention.

The variant, also known as B.1.617.2, was first detected in India in December and is spreading quickly across the globe. In some parts of America, the delta strain accounts for more than 80 per cent of new infections, including some Midwestern states like Missouri, Kansas and Iowa.

Story continues below Advertisement

It is already causing 74.3 per cent of infections in Western states, including Utah and Colorado, and 58.8 per cent of infections in Southern states like Texas, Louisiana, Arkansas and Oklahoma, according to CDC estimates.

New Covid infections with the Delta variant now account for 51.7 per cent of the infections. The B.1.1.7 or Alpha variant makes up for 28.7 per cent cases after remaining a dominant variant for months, the data said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show